Currently released so far... 51122 / 251,287

### Articles

Brazil Sri Lanka United Kingdom Sweden 00. Editorial United States Latin America Egypt Jordan Yemen Thailand

### Browse latest releases

2010/11 2010/12 2011/01 2011/02 2011/03 2011/04 2011/05 2011/06 2011/07 2011/08
2010/11/28 2010/11/29 2010/11/30
2010/12/01 2010/12/02 2010/12/03 2010/12/04 2010/12/05 2010/12/06 2010/12/07 2010/12/08 2010/12/09 2010/12/10 2010/12/11 2010/12/12 2010/12/13 2010/12/14 2010/12/15 2010/12/16 2010/12/17 2010/12/18 2010/12/19 2010/12/20 2010/12/21 2010/12/22 2010/12/23 2010/12/24 2010/12/25 2010/12/26 2010/12/27 2010/12/28 2010/12/29 2010/12/30
2011/01/01 2011/01/02 2011/01/04 2011/01/05 2011/01/07 2011/01/09 2011/01/11 2011/01/12 2011/01/13 2011/01/14 2011/01/15 2011/01/16 2011/01/17 2011/01/18 2011/01/19 2011/01/20 2011/01/21 2011/01/22 2011/01/23 2011/01/24 2011/01/25 2011/01/26 2011/01/27 2011/01/28 2011/01/29 2011/01/30 2011/01/31
2011/02/01 2011/02/02 2011/02/03 2011/02/04 2011/02/05 2011/02/06 2011/02/07 2011/02/08 2011/02/09 2011/02/10 2011/02/11 2011/02/12 2011/02/13 2011/02/14 2011/02/15 2011/02/16 2011/02/17 2011/02/18 2011/02/19 2011/02/20 2011/02/21 2011/02/22 2011/02/23 2011/02/24 2011/02/25 2011/02/26 2011/02/27 2011/02/28
2011/03/01 2011/03/02 2011/03/03 2011/03/04 2011/03/05 2011/03/06 2011/03/07 2011/03/08 2011/03/09 2011/03/10 2011/03/11 2011/03/13 2011/03/14 2011/03/15 2011/03/16 2011/03/17 2011/03/18 2011/03/19 2011/03/20 2011/03/21 2011/03/22 2011/03/23 2011/03/24 2011/03/25 2011/03/26 2011/03/27 2011/03/28 2011/03/29 2011/03/30 2011/03/31
2011/04/01 2011/04/02 2011/04/03 2011/04/04 2011/04/05 2011/04/06 2011/04/07 2011/04/08 2011/04/09 2011/04/10 2011/04/11 2011/04/12 2011/04/13 2011/04/14 2011/04/15 2011/04/16 2011/04/17 2011/04/18 2011/04/19 2011/04/20 2011/04/21 2011/04/22 2011/04/23 2011/04/24 2011/04/25 2011/04/26 2011/04/27 2011/04/28 2011/04/29 2011/04/30
2011/05/01 2011/05/02 2011/05/03 2011/05/04 2011/05/05 2011/05/06 2011/05/07 2011/05/08 2011/05/09 2011/05/10 2011/05/11 2011/05/12 2011/05/13 2011/05/14 2011/05/15 2011/05/16 2011/05/17 2011/05/18 2011/05/19 2011/05/20 2011/05/21 2011/05/22 2011/05/23 2011/05/24 2011/05/25 2011/05/26 2011/05/27 2011/05/28 2011/05/29 2011/05/30 2011/05/31
2011/06/01 2011/06/02 2011/06/03 2011/06/04 2011/06/05 2011/06/06 2011/06/07 2011/06/08 2011/06/09 2011/06/10 2011/06/11 2011/06/12 2011/06/13 2011/06/14 2011/06/15 2011/06/16 2011/06/17 2011/06/18 2011/06/19 2011/06/20 2011/06/21 2011/06/22 2011/06/23 2011/06/24 2011/06/25 2011/06/26 2011/06/27 2011/06/28 2011/06/29 2011/06/30
2011/07/01 2011/07/02 2011/07/04 2011/07/05 2011/07/06 2011/07/07 2011/07/08 2011/07/10 2011/07/11 2011/07/12 2011/07/13 2011/07/14 2011/07/15 2011/07/16 2011/07/17 2011/07/18 2011/07/19 2011/07/20 2011/07/21 2011/07/22 2011/07/23 2011/07/25 2011/07/27 2011/07/28 2011/07/29 2011/07/31
2011/08/01 2011/08/02 2011/08/03 2011/08/05 2011/08/06 2011/08/07 2011/08/08 2011/08/09 2011/08/10 2011/08/11 2011/08/12 2011/08/13 2011/08/15 2011/08/16 2011/08/17 2011/08/18 2011/08/19 2011/08/21 2011/08/22 2011/08/23 2011/08/24

### Browse by creation date

66 72 73 75 79 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10
1966/12
1972/02 1972/03 1972/08
1973/04 1973/10
1975/03
1979/08
1985/01 1985/02 1985/03 1985/05 1985/06 1985/10
1986/02 1986/05 1986/08 1986/09 1986/11 1986/12
1987/04 1987/06 1987/09 1987/12
1988/01 1988/03 1988/04 1988/07 1988/08 1988/09 1988/10 1988/12
1989/01 1989/03 1989/04 1989/06 1989/09 1989/12
1990/01 1990/02 1990/03 1990/07 1990/08 1990/10 1990/11
1991/01 1991/05 1991/06 1991/07 1991/08 1991/11
1992/01 1992/03 1992/06 1992/09 1992/11 1992/12
1993/01 1993/02 1993/04 1993/07 1993/10 1993/12
1994/05 1994/08 1994/11 1994/12
1995/01 1995/04 1995/06 1995/08 1995/09 1995/10 1995/11
1996/07 1996/08 1996/09 1996/11
1997/01 1997/02 1997/03 1997/05 1997/06 1997/08 1997/10 1997/11 1997/12
1998/05 1998/07 1998/08 1998/12
1999/01 1999/09 1999/10 1999/11 1999/12
2000/04 2000/05 2000/06 2000/09 2000/11 2000/12
2001/02 2001/03 2001/04 2001/05 2001/06 2001/07 2001/08 2001/09 2001/10 2001/11 2001/12
2002/01 2002/02 2002/03 2002/04 2002/05 2002/06 2002/07 2002/08 2002/09 2002/10 2002/11 2002/12
2003/01 2003/02 2003/03 2003/04 2003/05 2003/06 2003/07 2003/08 2003/09 2003/10 2003/11 2003/12
2004/01 2004/02 2004/03 2004/04 2004/05 2004/06 2004/07 2004/08 2004/09 2004/10 2004/11 2004/12
2005/01 2005/02 2005/03 2005/04 2005/05 2005/06 2005/07 2005/08 2005/09 2005/10 2005/11 2005/12
2006/01 2006/02 2006/03 2006/04 2006/05 2006/06 2006/07 2006/08 2006/09 2006/10 2006/11 2006/12
2007/01 2007/02 2007/03 2007/04 2007/05 2007/06 2007/07 2007/08 2007/09 2007/10 2007/11 2007/12
2008/01 2008/02 2008/03 2008/04 2008/05 2008/06 2008/07 2008/08 2008/09 2008/10 2008/11 2008/12
2009/01 2009/02 2009/03 2009/04 2009/05 2009/06 2009/07 2009/08 2009/09 2009/10 2009/11 2009/12
2010/01 2010/02

### Browse by origin

A B C D F G H I J K L M N O P Q R S T U V W Y Z
Embassy Athens Embassy Asuncion Embassy Astana Embassy Asmara Embassy Ashgabat Embassy Apia Embassy Antananarivo Embassy Ankara Embassy Amman Embassy Algiers Embassy Addis Ababa Embassy Accra Embassy Abuja Embassy Abu Dhabi Embassy Abidjan Consulate Auckland Consulate Amsterdam Consulate Alexandria Consulate Adana American Institute Taiwan, Taipei
Embasy Bonn Embassy Bujumbura Embassy Buenos Aires Embassy Budapest Embassy Bucharest Embassy Brussels Embassy Bridgetown Embassy Brazzaville Embassy Bratislava Embassy Brasilia Embassy Bogota Embassy Bishkek Embassy Bern Embassy Berlin Embassy Belmopan Embassy Belgrade Embassy Beirut Embassy Beijing Embassy Banjul Embassy Bangui Embassy Bangkok Embassy Bandar Seri Begawan Embassy Bamako Embassy Baku Embassy Baghdad Consulate Belfast Consulate Barcelona
Embassy Cotonou Embassy Copenhagen Embassy Conakry Embassy Colombo Embassy Chisinau Embassy Caracas Embassy Canberra Embassy Cairo Consulate Curacao Consulate Ciudad Juarez Consulate Chiang Mai Consulate Chennai Consulate Chengdu Consulate Casablanca Consulate Cape Town Consulate Calgary
Embassy Dushanbe Embassy Dublin Embassy Doha Embassy Djibouti Embassy Dili Embassy Dhaka Embassy Dar Es Salaam Embassy Damascus Embassy Dakar DIR FSINFATC Consulate Dusseldorf Consulate Durban Consulate Dubai Consulate Dhahran
Embassy Freetown Consulate Fukuoka Consulate Frankfurt
Embassy Guatemala Embassy Grenada Embassy Georgetown Embassy Gaborone Consulate Guayaquil Consulate Guangzhou Consulate Guadalajara
Embassy Helsinki Embassy Harare Embassy Hanoi Consulate Hong Kong Consulate Ho Chi Minh City Consulate Hermosillo Consulate Hamilton Consulate Hamburg Consulate Halifax
Iran RPO Dubai Embassy Islamabad Consulate Izmir Consulate Istanbul
Embassy Jakarta Consulate Johannesburg Consulate Jerusalem Consulate Jeddah
Embassy Kyiv Embassy Kuwait Embassy Kuala Lumpur Embassy Kolonia Embassy Kinshasa Embassy Kingston Embassy Kigali Embassy Khartoum Embassy Kathmandu Embassy Kampala Embassy Kabul Consulate Krakow Consulate Kolkata Consulate Karachi
Embassy Luxembourg Embassy Lusaka Embassy Luanda Embassy London Embassy Lome Embassy Ljubljana Embassy Lisbon Embassy Lima Embassy Lilongwe Embassy Libreville Embassy La Paz Consulate Leipzig Consulate Lahore Consulate Lagos
Mission USOSCE Mission USNATO Mission UNESCO Mission Geneva Embassy Muscat Embassy Moscow Embassy Montevideo Embassy Monrovia Embassy Mogadishu Embassy Minsk Embassy Mexico Embassy Mbabane Embassy Maseru Embassy Maputo Embassy Manila Embassy Manama Embassy Managua Embassy Malabo Embassy Madrid Consulate Munich Consulate Mumbai Consulate Montreal Consulate Monterrey Consulate Milan Consulate Merida Consulate Melbourne Consulate Matamoros Consulate Marseille
Embassy Nouakchott Embassy Nicosia Embassy Niamey Embassy New Delhi Embassy Ndjamena Embassy Nassau Embassy Nairobi Consulate Nuevo Laredo Consulate Naples Consulate Naha Consulate Nagoya
Embassy Ouagadougou Embassy Ottawa Embassy Oslo
Embassy Pristina Embassy Pretoria Embassy Praia Embassy Prague Embassy Port Of Spain Embassy Port Moresby Embassy Port Louis Embassy Port Au Prince Embassy Podgorica Embassy Phnom Penh Embassy Paris Embassy Paramaribo Embassy Panama Consulate Peshawar
Embassy Quito Consulate Quebec
REO Hillah REO Basrah Embassy Rome Embassy Riyadh Embassy Riga Embassy Reykjavik Embassy Rangoon Embassy Rabat Consulate Rio De Janeiro Consulate Recife
Secretary of State Embassy Suva Embassy Stockholm Embassy Sofia Embassy Skopje Embassy Singapore Embassy Seoul Embassy Sarajevo Embassy Santo Domingo Embassy Santiago Embassy Sanaa Embassy San Salvador Embassy San Jose Consulate Surabaya Consulate Strasbourg Consulate St Petersburg Consulate Shenyang Consulate Shanghai Consulate Sapporo Consulate Sao Paulo
Embassy Tunis Embassy Tripoli Embassy Tokyo Embassy Tirana Embassy The Hague Embassy Tel Aviv Embassy Tehran Embassy Tegucigalpa Embassy Tbilisi Embassy Tashkent Embassy Tallinn Consulate Toronto Consulate Tijuana Consulate Thessaloniki
USUN New York USMISSION USTR GENEVA USEU Brussels US Office Almaty US Mission Geneva US Mission CD Geneva US Interests Section Havana US Delegation, Secretary UNVIE UN Rome Embassy Ulaanbaatar
Embassy Vilnius Embassy Vientiane Embassy Vienna Embassy Vatican Embassy Valletta Consulate Vladivostok Consulate Vancouver
Embassy Windhoek Embassy Wellington Embassy Warsaw
Embassy Yerevan Embassy Yaounde Consulate Yekaterinburg
Embassy Zagreb

### Browse by tag

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
AMGT ASEC AEMR AR APECO AU AORC ADANA AJ AF AFIN AMED AS AM ABLD AFFAIRS AMB APER ACOA AND AA AE AADP AID AO AL AG AORD ADM AINF AINT ASEAN AORG ABT APEC AY ASUP ARF AGOA AVIAN ATRN ANET AGIT ASECVE ABUD AODE ALOW ADB AN ADPM ASPA ARABL AFSN AZ AC AIAG AFSI ASCE ASIG ACABQ ADIP AFGHANISTAN AROC ADCO ACOTA ANARCHISTS AMEDCASCKFLO AK ARABBL ASCH ANTITERRORISM AGRICULTURE AOCR ARR ASSEMBLY AORCYM AFPK ACKM AGMT AEC APRC AIN AFPREL ASFC ASECTH AFSA AINR AOPC AFAF AFARI AX ASECAF ASECAFIN AT AFZAL APCS AGAO AIT ARCH AEMRASECCASCKFLOMARRPRELPINRAMGTJMXL AMEX ARM AQ ATFN AMBASSADOR AORCD AVIATION ARAS AINFCY ACBAQ AOPR AREP AOIC ASEX ASEK AER AGR AMCT AVERY APR AEMRS AFU AMG ATPDEA ASECKFRDCVISKIRFPHUMSMIGEG AORL ACS AMCHAMS AECL AUC ACAO
BA BR BB BG BEXP BY BRUSSELS BU BD BTIO BK BL BE BMGT BO BM BX BN BWC BBSR BTT BC BH BILAT BUSH BHUM BT BTC BMENA BOND BAIO BP BF BRPA BURNS BUT BBG BCW BOEHNER BOL BASHAR BIDEN BFIN BZ BEXPC BTIU
CPAS CA CASC CS CBW CIDA CO CODEL CI CROS CU CH CWC CMGT CVIS CDG CTR CG CF CHIEF CJAN CBSA CE CY CB CW CM CHR CD COE CV COUNTER CT CN CPUOS CTERR CVR CVPR CDC COUNTRY CLEARANCE CONS COM CACS CR CONTROLS CAN CACM COMMERCE CAMBODIA CFIS COUNTERTERRORISM CITES CONDOLEEZZA CZ CTBT CEN CLINTON CFED CARC CTM CARICOM CSW CICTE CYPRUS CBE CMGMT CARSON CWCM CIVS COUNTRYCLEARANCE CENTCOM CAPC COPUOS CKGR CITEL CQ CITT CIC CARIB CVIC CAFTA CVISU CDB CEDAW CNC CJUS COMMAND CENTER COL CAJC CONSULAR CLMT CBC CIA CNARC CIS CEUDA CHINA CAC CL
DR DJ DEMOCRATIC DEMARCHE DOMESTIC DISENGAGEMENT DB DA DHS DAO DCM DAVID DO DEAX DEFENSE DEA DTRO DPRK DOC DTRA DK DAC DOD DRL DRC DCG DE DOT DEPT DOE DS DKEM
ECON ETTC EFIS ETRD EC EMIN EAGR EAID EFIN EUN ECIN EG EWWT EINV ENRG ELAB EPET EIND EN EAIR EUMEM ECPS ES EI ELTN ET EZ EU ER EINT ENGR ECONOMIC ENIV EFTA ETRN EMS EUREM EPA ESTH EEB EET ENV EAG EXIM ECTRD ELNT ENVIRONMENT ECA EAP EINDIR ETR ECONOMY ETRC ELECTIONS EICN EXPORT EARG EGHG EID ETRO EINF EAIDHO ECIP EENV EURM EPEC ERNG ENERG EIAD EXBS ED EREL ELAM EK EWT ENGRD EDEV ECE ENGY EXIMOPIC ETRDEC ECCT EUR ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID EFI ECOSOC EXTERNAL ESCAP ETCC EENG ERA ENRD ECLAC ETRAD EBRD ENVR ECONENRG ELTNSNAR ELAP EPIT EDUC EAIDXMXAXBXFFR EETC EIVN EDRC EGOV ETRA EAIDRW ETRDEINVECINPGOVCS ESA ETRDGK ENVI ELN EPRT EPTED ERTD EUM EAIDS EFINECONEAIDUNGAGM EDU EV EAIDAF EDA EPREL EINVEFIN EAGER ETMIN EUCOM ECCP EIDN EINVKSCA ENNP EFINECONCS ETC EAIRASECCASCID EINN ETRP ECONOMICS ENERGY EIAR EINDETRD ECONEFIN EURN ETRDEINVTINTCS EFIM ETIO EATO EIPR EINVETC ETTD ETDR EIQ ECONCS ENRGIZ EAIG ENTG EUC ERD EINVECONSENVCSJA EEPET EUNCH ESENV ECINECONCS ETRDECONWTOCS ECUN
FR FI FOREIGN FARM FIR FAO FK FARC FAS FJ FREEDOM FAC FINANCE FBI FTAA FM FCS FAA FORCE FDA FTA FT FCSC FMGT FINR FIN FDIC FOR FOI FO FMLN FISO
GM GERARD GT GA GG GR GTIP GH GZ GE GB GY GAZA GJ GEORGE GOI GCC GMUS GI GLOBAL GV GC GL GOV GKGIC GF GWI GIPNC GUTIERREZ GTMO GANGS GAERC GUILLERMO GASPAR
HR HA HYMPSK HO HK HUMAN HU HN HHS HURI HUD HUMRIT HUMANITARIAN HUMANR HL HSTC HILLARY HCOPIL HADLEY HOURANI HI HUM HEBRON HUMOR
IZ IN IAEA IS IMO ILO IR IC IT ITU ID IV IMF IBRD IWC ICAO ICRC INF IO IPR ISO IK ISRAELI IQ ICES IDB INFLUENZA IRAQI ISCON IGAD IRAN ITALY IRAQ ICTY ICTR ITPGOV ITALIAN IQNV IADB INTERNAL INMARSAT IRDB ILC INCB INRB ICJ ISRAEL INR IEA ISPA ICCAT IOM ITRD IHO IL IFAD ITRA IDLI ISCA INL INRA INTELSAT ISAF ISPL IRS IEF ITER INDO IIP IND IEFIN IACI IAHRC INNP IA INTERPOL IFIN ISSUES IZPREL IRAJ IF ITPHUM ITA IP IRPE IDA ISLAMISTS ITF INRO IBET IDP IRC
JA JO JM JP JCIC JOSEPH JAPAN JOHN JE JS JUS JN JOHNNIE JKUS JAMES JML JIMENEZ JK
KMDR KPAO KOMC KNNP KFLO KDEM KSUM KIPR KFLU KE KCRM KJUS KAWC KZ KSCA KDRG KCOR KGHG KPAL KTIP KMCA KCRS KPKO KOLY KRVC KVPR KG KWBG KTER KS KN KSPR KWMN KV KTFN KFRD KU KSTC KSTH KISL KGIC KSEP KFIN KTEX KTIA KUNR KCMR KCIP KMOC KTDB KBIO KBCT KMPI KSAF KACT KFEM KPRV KPWR KIRC KCFE KRIM KHIV KHLS KVIR KNNNP KCEM KLIG KIRF KNUP KSAC KNUC KPGOV KTDD KIDE KOMS KLFU KNNC KMFO KSEO KJRE KJUST KMRS KSRE KGIT KPIR KPOA KUWAIT KIVP KICC KSCS KPOL KSEAO KRCM KSCI KNAP KGLB KICA KCUL KPRM KFSC KQ KPOP KPFO KPALAOIS KREC KBWG KR KTTB KNAR KCOM KESS KINR KOCI KWN KCSY KREL KTBT KFTN KW KRFD KFLOA KHDP KNEP KIND KHUM KSKN KOMO KDRL KTFIN KSOC KPO KGIV KSTCPL KSI KPRP KFPC KNNB KNDP KICCPUR KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG KDMR KFCE KIMMITT KMCC KMNP KSEC KOMCSG KGCC KRAD KCRP KAUST KWAWC KCHG KRDP KPAS KTIAPARM KPAOPREL KWGB KIRP KMIG KLAB KSEI KHSA KNPP KPAONZ KWWW KGHA KY KCRIM KCRCM KGCN KPLS KIIP KPAOY KTRD KTAO KJU KBTS KWAC KFIU KNNO KPAI KILS KPA KRCS KWBGSY KNPPIS KNNPMNUC KNPT KERG KLTN KPREL KTLA KO KAWK KVRP KAID KX KENV KWCI KNPR KCFC KNEI KFTFN KTFM KCERS KDEMAF KMEPI KEMS KBTR KEDU KIRL KNNR KMPT KPDD KPIN KDEV KFRP KTBD KMSG KWWMN KWBC KA KOM KWNM KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG KRGY KNNF KICR KIFR KWMNCS KPAK KDDG KCGC KID KNSD KMPF KWMM
LY LE LABOR LH LI LO LN LT LAB LTTE LU LG LA LB LOTT LVPR LAW LAURA LS LOVE LR LOG
MARR MX MASS MOPS MNUC MCAP MTCRE MRCRE MTRE MASC MY MK MG MU MILI MO MZ MEPP MCC MEDIA MOPPS MI MAS MW MP MEPN MV MD MR MC MCA MT MIL MARITIME MOPSGRPARM MAAR MOOPS ML MA MN MNUCPTEREZ MTCR MUNC MPOS MONUC MGMT MURRAY MACP MINUSTAH MCCONNELL MGT MNUR MF MEPI MOHAMMAD MAR MAPP MNU MFA MTS MLS MEETINGS MERCOSUR MED MNVC MIK MBM MILITARY MAPS MARAD MDC MACEDONIA MASSMNUC MUCN MQADHAFI MPS
NZ NATO NI NO NU NG NL NPT NS NA NP NASA NSF NEA NANCY NSG NRR NATIONAL NMNUC NC NSC NAS NARC NELSON NATEU NDP NIH NK NIPP NR NERG NSSP NE NTDB NT NEGROPONTE NGO NATOIRAQ NAR NZUS NCCC NH NAFTA NEW NRG NUIN NOVO NATOPREL NV NICHOLAS NPA NSFO NW NORAD NPG NOAA
OPRC OPDC OTRA OECD OVIP OREP ODC OIIP OAS OSCE OPIC OMS OFDP OFDA OEXC OPCW OIE OSCI OM OPAD ODPC OIC ODIP OPPI ORA OCEA OREG OMIG OFFICIALS OSAC OEXP OPEC OFPD OAU OCII OIL OVIPPRELUNGANU OSHA OPCD OPCR OF OFDPQIS OSIC OHUM OTR OBSP OGAC OESC OVP ON OES OTAR OCS
PREL PGOV PARM PINR PHUM PM PREF PTER PK PINS PBIO PHSA PE PBTS PA PL POL PAK POV POLITICS POLICY PO PRELTBIOBA PKO PIN PNAT PU PGOVPREL PALESTINIAN PTERPGOV PELOSI PAS PP PTEL PROP PRELAF PRHUM PRE PUNE PIRF PVOV PROG PERSONS PROV PKK PRGOV PH PLAB PDEM PCI PRL PRM PINSO PERM PETR PPAO PERL PBS PETERS PRELBR PCON POLITICAL PMIL POLM PKPA PNUM PLO PTERM PJUS PARMP PNIR PHUMKPAL PG PREZ PGIC PAO PROTECTION PRELPK PGOVENRG PATTY PSOC PARTIES PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ PMIG PAIGH PARK PETER PHUS PKPO PGOVECON POUS PMAR PWBG PAR PGOVGM PHUH PTE PY POLUN PDOV PGOVSOCI PGOVPM PRELEVU PGOR PBTSRU PHUMA PHUMR PPD PGV PRAM PARMS PINL PSI PKPAL PPA PTERE PGOF PINO PREO PHAS PAC PRESL PORG PS PGVO PKFK PSOE PEPR PINT PRELP PREFA PNG PTBS PFOR PGOVLO PHUMBA PREK PHJM POLINT PGOVE PHALANAGE PARTY PECON PEACE PROCESS PLN PEDRO PF PGPV PCUL PGGV PSA PGOVSMIGKCRMKWMNPHUMCVISKFRDCA PGIV PHUMPREL POGOV PEL PBT PAMQ PINF PSEPC POSTS PAHO PHUMPGOV PGOC PNR
QA QI QT QM QADRI
RS RP RU RW RFE RCMP RIGHTSPOLMIL REFORM RO ROW ROBERT REACTION REPORT REGION RELATIONS RAY ROBERTG RIGHTS RM RATIFICATION RREL RBI RICE ROOD REL RODHAM RGY RUEHZO RELIGIOUS RELFREE RUEUN RELAM RSP RF REO REGIONAL RUPREL RI REMON RPEL RSO
SCUL SENV SOCI SZ SNAR SO SP SU SY SI SMIG SYR SA SW SF SR SYRIA SNARM START SPECIALIST SG SNIG SCI SGWI SE SIPDIS SANC SELAB SN SETTLEMENTS SCIENCE SENVENV SENS SPCE SPAS SECURITY SENC SOCIETY SOSI SENVEAGREAIDTBIOECONSOCIXR SEN SPECI ST SL SENVCASCEAIDID SC SECRETARY STR SNA SOCIS SADC SEP SK SHUM SYAI SMIL STEPHEN SNRV SKCA SENSITIVE SECI SCUD SCRM SGNV SECTOR SAARC SENVSXE SWMN STEINBERG SOPN SOCR SCRS SWE SARS SNARIZ SUDAN SENVQGR SAN SM SFNV SSA SPCVIS SOFA SCULKPAOECONTU SENVKGHG SHI SEVN SH SNARCS SNARN SIPRS
TBIO TW TRGY TSPA TU TPHY TI TX TH TIP TSPL TNGD TZ TS TC TK TURKEY TERRORISM TPSL TINT TRSY TERFIN TPP TT TECHNOLOGY TE TAGS TRAFFICKING TJ TN TO TD TP TREATY TR TA TIO TECH TF TRAD TNDG TWI TPSA TWL TAUSCHER TRBY TL TV THPY TSPAM TREL TRT TNAR TFIN TWCH THOMMA THOMAS TERROR TRY TBID
UK UNESCO UNSC UNGA UN US UZ USEU UG UP UNAUS UNMIK USTR UY USUN UNEP UNDC UV UNPUOS UNSCR USAID UNODC UNRCR UNHCR UNDP UNCRIME UA UNHRC UNRWA UNO UNCND UNCHR USAU UNICEF USPS UNOMIG UNESCOSCULPRELPHUMKPALCUIRXFVEKV UR UNFICYP UNCITRAL UNAMA UNVIE USTDA USNC UNCSD USCC UNEF UNGAPL USSC UNMIC UNTAC UNCLASSIFIED USDA UNCTAD USGS UNFPA UNSE USOAS UE UAE UNCHS UNDESCO UNC UNSCS UKXG UNGACG UNHR UNBRO UNCHC UNFCYP UNIDROIT
VE VM VT VZ VEPREL VN VEN VTPREL VC VTEG VOA VTEAID VTIZ VISIT VENZ VAT VI
WHTI WIPO WTRO WHO WTO WMO WFP WEET WS WE WA WHA WBG WILLIAM WI WSIS WCL WEBZ WZ WW WWBG WMD WWT WMN WWARD WITH WTRQ WCO WEU WB WBEG
XA XX XW XK XL XM XS XF XH XB XG XT XR XY XO XD XV XI XE XC XJ XU XZ XQ XP XFNEA XTAG
YM YI YE YMOEXC YL YMCS
ZU ZI ZM ZK ZP ZOELLICK ZR ZF ZA ZL ZO ZJ ZANU ZB ZN ZH ZT ZFR ZEALAND ZXA

### Browse by classification

CONFIDENTIAL CONFIDENTIAL//NOFORN SECRET SECRET//NOFORN UNCLASSIFIED UNCLASSIFIED//FOR OFFICIAL USE ONLY

### Community resources

Follow us on Twitter Check our Reddit Twitter this Digg this page Contact us on IRC

courage is contagious

### Viewing cable 05ANKARA394, GOT's New Data Exclusivity Regulation - Major

If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:

- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.

To understand the justification used for the classification of each cable, please use this WikiSource article as reference.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #05ANKARA394.

Reference ID | Created | Released | Classification | Origin
--- | --- | --- | --- | ---
05ANKARA394 | 2005-01-25 15:35 | 2011-08-24 01:00 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Embassy Ankara

`

    This record is a partial extract of the original cable. The full text of the original cable is not available.

` `

    UNCLAS SECTION 01 OF 02 ANKARA 000394

    SIPDIS

    DEPT FOR E, EB/TPP/MTA/IPC, EUR/ERA, EUR/SE
    USTR FOR LERRION/BPECK
    USEU FOR CHRIS WILSON
    USPTO FOR ELAINE WU
    USDOC FOR ITA/MAC/DDEFALCO

    SENSITIVE

    E.O. 12958: N/A
    TAGS: ETRD KIPR TU
    SUBJECT:  GOT's New Data Exclusivity Regulation - Major
    Gaps in Protection

    SENSITIVE BUT UNCLASSIFIED.  PLEASE HANDLE ACCORDINGLY.

    ¶1. (SBU) Summary:  The GOT issued a revised regulation
    on January 19 providing a six-year term of data
    exclusivity protection for confidential pharmaceuticals
    test data effective January 1, 2005.  The regulation
    contains major loopholes, including lack of
    retroactivity and other provisions which effectively
    whittle down the six-year term.  The European Commission
    is evaluating Turkey's regulation in the context of its
    Trade Barrier Review (TBR) on barriers in the
    pharmaceuticals sector.  Research-based industry is also
    meeting to consider next steps.  End Summary.

    ¶2. (U) On January 19, the GOT announced its long-awaited
    policy on data exclusivity by publishing a revised
    pharmaceuticals marketing regulation in the State
    Gazette.  Based on a preliminary review of the
    regulation (see para for 5 a translation provided by
    Pfizer) and comments by one U.S. company, the policy
    seems similar to earlier, unsatisfactory drafts on data
    exclusivity.  The regulation provides a six-year term of
    data exclusivity protection beginning on January 1,
    2005, and in certain cases, beginning in 2001, but with
    exceptions that could reduce its benefits to research-
    based companies.  These include:

    -- Starting the six-year term on the date of licensing
    in an EU Customs Union country.  According to Pfizer,
    this provision cuts the effective term of protection
    because it can take over 200 days for a drug to go
    through the marketing approval process in Turkey;

    -- Limiting the term of data exclusivity to the term of
    the drug's patent in Turkey.  Note:  A Pfizer
    representative told us that this is unhelpful, but not
    inconsistent with existing EU regulations.  End Note;

    -- Original products licensed in a Customs Union country
    after January 1, 2001 can enjoy data exclusivity
    protection, unless generics manufacturers have applied
    for licenses in Turkey prior to 2005.  According to U.S.
    industry, there are hundreds, and possibly over 1,000
    pending applications in this category at the Ministry of
    Health.  With this vast loophole, relatively few drugs
    launched prior to 2005 will be able to benefit from data
    exclusivity protection.

    ¶3. (SBU) An EU diplomat told us that the GOT had
    provided no advance notice to Brussels of this
    regulation, despite the fact that the European
    Commission had raised data exclusivity and other
    pharmaceuticals concerns with the Turks in writing
    through the TBR process.  She told Econoff that Brussels
    would evaluate the regulation in meetings later this
    week.

    ¶4. (SBU) Comment and Recommendation:  It appears that
    the new GOT regulation falls far short of a satisfactory
    solution to our concerns on data exclusivity, and that
    this issue, along with patent linkage, will be leading
    subjects in the upcoming Special 301 review of Turkey.
    Although the EU declined an earlier U.S. request to do a
    joint demarche on this subject to the Turks, the time
    may be ripe for another approach to Brussels.  We
    recommend that Washington agencies consider the merits
    of a joint demarche, and, if appropriate, provide
    guidance to the Embassy and to USEU.

    ¶5. (U) Begin Text Pfizer Translation - Registration
    Regulation Article 9/Temporary Article 1:

    Article 9- Without prejudice to the provisions of the
    Decree Law dated 24/06/1995,with no. 551, on the
    Protection of Patent Rights;
    a) In abridged applications, the applicant shall not be
    required to present the results of toxicological and
    pharmacological tests and clinical trials, provided that
    one of the following points is proved:
    1) The medicinal product shall be mostly similar to a
    medicinal product which previously registered in Turkey
    and the marketing registration holder of the original
    medicinal product shall have consented to the use of the
    toxicological, pharmacological and/or clinical
    references contained in the dossier of the original
    medicinal product for the purpose of evaluating the
    referred application,
    2) Any constituent(s) of the medicinal product shall
    have a well-established medical use, determined by means
    of detailed scientific bibliography and with a
    reasonable efficiency and acceptable level of
    reliability,
    3) The medicinal product shall be essentially similar
    with a medicinal product which has been registered in
    accordance with the current legislative provisions and
    has completed its data exclusivity period. The data
    exclusivity period called for by this subparagraph,
    shall apply on the original products for which no
    generic registration application has been submitted in
    Turkey until 01/01/2005, among the original products
    registered for the first time after 01/01/2001 in one of
    the countries within the Customs Union Area and the
    original products to be registered for the time after
    01/01/2005 in one of the countries of the Customs Union
    Area and shall be 6 (six) years to begin as of the first
    registration date in the Customs Union Area and to be
    limited with the patent period of the  relevant molecule
    in Turkey.
    However, in the event of a different therapeutical
    indication, route of administration, dosage being
    envisaged from those of the medicinal products which
    have been introduced into the market, it shall be
    necessary to submit the results of the relevant clinical
    trials and where necessary the results of toxicological,
    pharmacological studies.
    b) With regard to new medicinal products containing
    recognized constituents, but which have not yet been
    used in combination for therapeutical purposes, it shall
    be necessary to present the results of the relevant
    toxicological and pharmacological tests and clinical
    trials. However, it shall not be obligatory to present
    the references pertaining to each constituent.
    In compliance with subparagraph (2) in item (a) of the
    first paragraph of this article, in the event of the
    presentation of bibliographical references based on
    published data, the applications shall be submitted in
    accordance with Annex I.
    In exceptional cases constituting a severe threat for
    public health, the Ministry may take into consideration
    the registration applications of generic products, which
    have been presented upon taking as basis the data
    pertaining to the toxicological, pharmacological and
    clinical data published on literature, independent from
    the provisions set forth in this article.

    Temporary Article 1- The registration/permit
    applications submitted before the enforcement of this
    Regulation, shall be evaluated in accordance with the
    legislative provisions in force on the date such
    applications are submitted.
    With regard to the abridged applications presented in
    accordance with article 9 of this Regulation of which
    all provisions except for article 9 shall be enforced on
    30/06/2005, the applications submitted in compliance
    with the application format indicated in the Regulation
    in force shall be accepted.

    End Text Pfizer Translation.

    Edelman

`